fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Progress on early detection of Alzheimer’s disease

Written by | 19 Jun 2022

Inside the body, some seemingly harmless proteins have sinister potential. In the case of Alzheimer’s disease, the amyloid-beta (Aβ) protein, which is vital for brain growth, can become… read more.

How can mental health professionals open their minds to psychosis?

Written by | 11 May 2022

Effective clinical care for patients with psychosis means understanding the ‘lived experience’ of their delusions, say researchers at the Universities of Birmingham, York and Melbourne. By understanding the… read more.

Electroconvulsive therapy (ECT) halves suicide at a year post-hospitalization

Written by | 2 May 2022

Electroconvulsive therapy (ECT) led to a 47 per cent reduction suicide risk among depressed patients for a year after hospitalization. The findings were reported on April 26, 2022… read more.

Psychiatric symptoms in Alzheimers disease

Written by | 20 Apr 2022

In addition to memory problems and other cognitive symptoms, most people with Alzheimer’s disease also suffer from mental health issues. It has long been unclear whether these occur… read more.

Lifestyle significantly affects number of years lived with Alzheimer’s

Written by | 14 Apr 2022

A healthy lifestyle is not only linked with a longer life expectancy but also less frequency and length of Alzheimer’s dementia, researchers reported on April 13, 2022 in… read more.

Cases of cognitive decline in older people more than double in ten years

Written by | 29 Mar 2022

The researchers set out to see if there had been an increase in the numbers of older people who were reporting their first concerns about memory loss or… read more.

Ketamine is effective for severe suicidal ideation

Written by | 16 Feb 2022

Ketamine is effective for the acute treatment of severe suicidal ideation, researchers reported on February 2, 2022 in The BMJ/British Medical Journal. “This study confirmed in a large… read more.

Update on the phase IV confirmatory study of Aduhelm for Alzheimer’s disease – Biogen + Eisai

Written by | 31 Jan 2022

Biogen Inc. and Eisai Co., Ltd. provided an important update on the continuing progress of the Phase IV post-marketing confirmatory study of Aduhelm (aducanumab-avwa) 100 mg/mL injection for… read more.

Identifying rare disease-associated genetic variants in patients with severe schizophrenia

Written by | 28 Dec 2021

New research published in the Proceedings of the National Academy of Sciences shows that examining genetic mutations in individuals with severe schizophrenia can improve the ability to detect disease-associated rare… read more.

Scientists discover potential cause of Alzheimer’s Disease

Written by | 7 Dec 2021

Existing drugs may offer effective treatment. Prevailing theories posit plaques in the brain cause Alzheimer’s disease. New UC Riverside research points to cells’ slowing ability to clean themselves… read more.

Researchers boost human mental function with brain stimulation

Written by | 27 Nov 2021

In a pilot human study, researchers from the University of Minnesota Medical School and Massachusetts General Hospital show it is possible to improve specific human brain functions related… read more.

Lithium imaging method could shine new light on bipolar disorder, treatment

Written by | 5 Nov 2021

Since 1949, lithium has been a mainstay for treating bipolar disorder (BD), a mental health condition marked by extreme mood swings. But scientists still don’t have a clear… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.